Quarterly report pursuant to Section 13 or 15(d)

Condensed Statement Of Cash Flows

v3.8.0.1
Condensed Statement Of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash Flows from Operating Activities:    
Net loss $ (2,074,873) $ (21,611,024)
Adjustments to reconcile net loss to net cash used in operating activities:    
Compensatory stock 12,150 12,750
Depreciation and amortization 14,600 8,927
Amortization of premiums and discounts on marketable securities, net 14,907 5,773
Stock-based compensation 296,577 274,327
Amortization and termination of deferred research and development arrangement (375,000) (18,750)
Unrealized (gain) loss on fair value of warrants (3,366,496) 17,689,580
Amortization of deferred lease incentive (3,111) (3,111)
Deferred lease expenses (5,463) (3,585)
Changes in assets and liabilities:    
Prepaid expenses and other assets 73,276 (356,608)
Accounts payable and accrued expenses (184,905) (167,014)
Net Cash Used in Operating Activities (5,598,338) (4,168,735)
Cash Flows from Investing Activities:    
Purchase of equipment (2,520) (3,965)
Purchase of marketable securities   (2,005,700)
Redemption of marketable securities 3,000,000 2,720,000
Net Cash Provided by Investing Activities 2,997,480 710,335
Cash Flows from Financing Activities:    
Proceeds from exercise of stock warrants   2,366,106
Net Cash Provided by Financing Activities   2,366,106
Net Decrease in Cash and Cash Equivalents (2,600,858) (1,092,294)
Cash and Cash Equivalents - beginning of period 8,899,154 11,578,473
Cash and Cash Equivalents - end of period $ 6,298,296 10,486,179
Non-cash financing and investing activties:    
Warrant liability extinguishment from exercise of warrants   3,029,115
Stock subscription receivable from warrants exercised   $ 30,000